Alejandro Porras-Segovia1,2, Isaac Díaz-Oliván3,4,5, Luis Gutiérrez-Rojas6,7, Henry Dunne8, Manon Moreno3,4, Enrique Baca-García3,4,5,9,10,11,12,13. 1. Department of Psychiatry, Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Madrid, Spain. alexposeg@gmail.com. 2. Department of Psychiatry, Hospital Rey Juan Carlos, Móstoles, Spain. alexposeg@gmail.com. 3. Department of Psychiatry, Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Madrid, Spain. 4. Department of Psychiatry, Hospital Rey Juan Carlos, Móstoles, Spain. 5. Madrid Autonomous University, Madrid, Spain. 6. Department of Psychiatry, Universidad de Granada, Granada, Spain. 7. Unidad de Hospitalización del Hospital Campus de la Salud, Complejo Hospitalario de Granada, Granada, Spain. 8. Brighton & Sussex University Hospital, Brighton, UK. 9. CIBERSAM (Centro de Investigación en Salud Mental), Carlos III Institute of Health, Madrid, Spain. 10. Universidad Catolica del Maule, Talca, Chile. 11. Department of Psychiatry, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain. 12. Department of Psychiatry, General Hospital of Villalba, Madrid, Spain. 13. Department of Psychiatry, University Hospital Infanta Elena, Valdemoro, Spain.
Abstract
PURPOSE OF REVIEW: To summarize the latest evidence about mobile phone applications for the management of depression. RECENT FINDINGS: Depression apps are very heterogeneous, given the absence of standards for their development, description, and evaluation. Randomized clinical trials show the effectiveness of some of these applications in reducing depressive symptoms. Attrition is an important issue whose evaluation is limited by the frequent use of incentives in the studies. The number of mobile applications for depression far exceeds the number of studies evaluating their efficacy and feasibility. Despite the limitations of the digital market, there are a small number of apps that have demonstrated sufficient effectiveness and tolerability to think of short-term clinical use. However, there are still barriers at different levels that may delay the implementation of these interventions in daily clinical practice.
PURPOSE OF REVIEW: To summarize the latest evidence about mobile phone applications for the management of depression. RECENT FINDINGS:Depressionapps are very heterogeneous, given the absence of standards for their development, description, and evaluation. Randomized clinical trials show the effectiveness of some of these applications in reducing depressive symptoms. Attrition is an important issue whose evaluation is limited by the frequent use of incentives in the studies. The number of mobile applications for depression far exceeds the number of studies evaluating their efficacy and feasibility. Despite the limitations of the digital market, there are a small number of apps that have demonstrated sufficient effectiveness and tolerability to think of short-term clinical use. However, there are still barriers at different levels that may delay the implementation of these interventions in daily clinical practice.
Authors: Graham J Emslie; Betsy D Kennard; Taryn L Mayes; Paul A Nakonezny; Lian Zhu; Rongrong Tao; Carroll Hughes; Paul Croarkin Journal: J Child Adolesc Psychopharmacol Date: 2012-01-18 Impact factor: 2.576
Authors: D Bennabi; B Aouizerate; W El-Hage; O Doumy; F Moliere; P Courtet; I Nieto; F Bellivier; M Bubrovsky; G Vaiva; J Holztmann; T Bougerol; R Richieri; C Lancon; V Camus; G Saba; F Haesbaert; T d'Amato; T Charpeaud; P M Llorca; M Leboyer; E Haffen Journal: J Affect Disord Date: 2014-10-08 Impact factor: 4.839
Authors: Patricia A Arean; Kevin A Hallgren; Joshua T Jordan; Adam Gazzaley; David C Atkins; Patrick J Heagerty; Joaquin A Anguera Journal: J Med Internet Res Date: 2016-12-20 Impact factor: 5.428
Authors: Hannah Wisniewski; Gang Liu; Philip Henson; Aditya Vaidyam; Narissa Karima Hajratalli; Jukka-Pekka Onnela; John Torous Journal: Evid Based Ment Health Date: 2019-01-11
Authors: John Torous; Sandra Bucci; Imogen H Bell; Lars V Kessing; Maria Faurholt-Jepsen; Pauline Whelan; Andre F Carvalho; Matcheri Keshavan; Jake Linardon; Joseph Firth Journal: World Psychiatry Date: 2021-10 Impact factor: 49.548
Authors: Alba Hernández-Gómez; María José Valdés-Florido; Guillermo Lahera; Nelson Andrade-González Journal: Front Psychiatry Date: 2022-08-12 Impact factor: 5.435